Publicacions en col·laboració amb investigadors/es de Fred Hutchinson Cancer Research Center (35)

2023

  1. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

    Annals of Epidemiology, Vol. 77, pp. 1-12

  2. IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer

    Journal of Thoracic Oncology, Vol. 18, Núm. 5, pp. 564-575

2022

  1. Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies

    Gut, Vol. 71, Núm. 6, pp. 1095-1105

2021

  1. Considerations for treatment duration in responders to immune checkpoint inhibitors

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

  2. Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

    Leukemia, Vol. 35, Núm. 12, pp. 3542-3550

  3. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma

    Brain, Vol. 144, Núm. 1, pp. 53-69

  4. The International Association for the Study of Lung Cancer Molecular Database Project: Objectives, Challenges, and Opportunities

    Journal of Thoracic Oncology

2020

  1. A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma

    Leukemia, Vol. 34, Núm. 12, pp. 3298-3309

  2. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis

    The Lancet Haematology, Vol. 7, Núm. 10, pp. e746-e755

  3. Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade

    GLIA, Vol. 68, Núm. 10, pp. 2148-2166

  4. Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma

    PLoS ONE, Vol. 15, Núm. 9 September

  5. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer

    Journal of Thoracic Oncology, Vol. 15, Núm. 3, pp. 344-359

  6. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis

    Journal of Thrombosis and Haemostasis, Vol. 18, Núm. 8, pp. 1940-1951

2019

  1. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

    Leukemia, Vol. 33, Núm. 1, pp. 159-170

2018

  1. Body mass index is negatively associated with telomere length: A collaborative cross-sectional meta-analysis of 87 observational studies

    American Journal of Clinical Nutrition, Vol. 108, Núm. 3, pp. 453-475

  2. Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

    Annals of Oncology, Vol. 29, Núm. 2, pp. 405-417

  3. Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility

    Nature Communications, Vol. 9, Núm. 1

  4. Metabolic predictors of incident coronary heart disease in women

    Circulation, Vol. 137, Núm. 8, pp. 841-853

  5. The IASLC Lung Cancer Staging Project: A Renewed Call to Participation

    Journal of Thoracic Oncology, Vol. 13, Núm. 6, pp. 801-809

2016

  1. Associations of the MCM6-rs3754686 proxy for milk intake in Mediterranean and American populations with cardiovascular biomarkers, disease and mortality: Mendelian randomization

    Scientific Reports, Vol. 6